171 related articles for article (PubMed ID: 37273120)
1. New Dominant-Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130-Dependent Hyper-IgE Syndrome.
Arlabosse T; Materna M; Riccio O; Schnider C; Angelini F; Perreau M; Rochat I; Superti-Furga A; Campos-Xavier B; Héritier S; Pereira A; Deswarte C; Lévy R; Distefano M; Bustamante J; Roelens M; Borie R; Le Brun M; Crestani B; Casanova JL; Puel A; Hofer M; Fieschi C; Theodoropoulou K; Béziat V; Candotti F
J Clin Immunol; 2023 Oct; 43(7):1566-1580. PubMed ID: 37273120
[TBL] [Abstract][Full Text] [Related]
2. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome.
Béziat V; Tavernier SJ; Chen YH; Ma CS; Materna M; Laurence A; Staal J; Aschenbrenner D; Roels L; Worley L; Claes K; Gartner L; Kohn LA; De Bruyne M; Schmitz-Abe K; Charbonnier LM; Keles S; Nammour J; Vladikine N; Maglorius Renkilaraj MRL; Seeleuthner Y; Migaud M; Rosain J; Jeljeli M; Boisson B; Van Braeckel E; Rosenfeld JA; Dai H; Burrage LC; Murdock DR; Lambrecht BN; Avettand-Fenoel V; Vogel TP; ; Esther CR; Haskologlu S; Dogu F; Ciznar P; Boutboul D; Ouachée-Chardin M; Amourette J; Lebras MN; Gauvain C; Tcherakian C; Ikinciogullari A; Beyaert R; Abel L; Milner JD; Grimbacher B; Couderc LJ; Butte MJ; Freeman AF; Catherinot É; Fieschi C; Chatila TA; Tangye SG; Uhlig HH; Haerynck F; Casanova JL; Puel A
J Exp Med; 2020 Jun; 217(6):. PubMed ID: 32207811
[TBL] [Abstract][Full Text] [Related]
3. Functional and structural analysis of cytokine-selective IL6ST defects that cause recessive hyper-IgE syndrome.
Chen YH; Zastrow DB; Metcalfe RD; Gartner L; Krause F; Morton CJ; Marwaha S; Fresard L; Huang Y; Zhao C; McCormack C; Bick D; Worthey EA; Eng CM; Gold J; Undiagnosed Diseases Network ; Montgomery SB; Fisher PG; Ashley EA; Wheeler MT; Parker MW; Shanmugasundaram V; Putoczki TL; Schmidt-Arras D; Laurence A; Bernstein JA; Griffin MDW; Uhlig HH
J Allergy Clin Immunol; 2021 Aug; 148(2):585-598. PubMed ID: 33771552
[TBL] [Abstract][Full Text] [Related]
4. The Human GP130 Cytokine Receptor and Its Expression-an Atlas and Functional Taxonomy of Genetic Variants.
Chen YH; van Zon S; Adams A; Schmidt-Arras D; Laurence ADJ; Uhlig HH
J Clin Immunol; 2023 Dec; 44(1):30. PubMed ID: 38133879
[TBL] [Abstract][Full Text] [Related]
5. Selective loss of function variants in
Shahin T; Aschenbrenner D; Cagdas D; Bal SK; Conde CD; Garncarz W; Medgyesi D; Schwerd T; Karaatmaca B; Cetinkaya PG; Esenboga S; Twigg SRF; Cant A; Wilkie AOM; Tezcan I; Uhlig HH; Boztug K
Haematologica; 2019 Mar; 104(3):609-621. PubMed ID: 30309848
[TBL] [Abstract][Full Text] [Related]
6. Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experience.
Shamriz O; Rubin L; Simon AJ; Lev A; Barel O; Somech R; Korem M; Matza Porges S; Freund T; Hagin D; Garty BZ; Nahum A; Molho Pessach V; Tal Y
Front Immunol; 2022; 13():1044933. PubMed ID: 36605204
[TBL] [Abstract][Full Text] [Related]
7. Clinical Profile of Hyper-IgE Syndrome in India.
Saikia B; Rawat A; Minz RW; Suri D; Pandiarajan V; Jindal A; Sahu S; Karim A; Desai M; Taur PD; Pandrowala A; Gowri V; Madkaikar M; Dalvi A; Yadav RM; Lashkari HP; Raj R; Uppuluri R; Swaminathan VV; Bhattad S; Cyril G; Kumar H; Shukla A; Kalra M; Govindaraj G; Singh S
Front Immunol; 2021; 12():626593. PubMed ID: 33717144
[No Abstract] [Full Text] [Related]
8. Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance.
Asano T; Khourieh J; Zhang P; Rapaport F; Spaan AN; Li J; Lei WT; Pelham SJ; Hum D; Chrabieh M; Han JE; Guérin A; Mackie J; Gupta S; Saikia B; Baghdadi JEI; Fadil I; Bousfiha A; Habib T; Marr N; Ganeshanandan L; Peake J; Droney L; Williams A; Celmeli F; Hatipoglu N; Ozcelik T; Picard C; Abel L; Tangye SG; Boisson-Dupuis S; Zhang Q; Puel A; Béziat V; Casanova JL; Boisson B
J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34137790
[TBL] [Abstract][Full Text] [Related]
9. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.
Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L
J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791
[TBL] [Abstract][Full Text] [Related]
10. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation.
Siegel AM; Stone KD; Cruse G; Lawrence MG; Olivera A; Jung MY; Barber JS; Freeman AF; Holland SM; O'Brien M; Jones N; Nelson CG; Wisch LB; Kong HH; Desai A; Farber O; Gilfillan AM; Rivera J; Milner JD
J Allergy Clin Immunol; 2013 Dec; 132(6):1388-96. PubMed ID: 24184145
[TBL] [Abstract][Full Text] [Related]
11. Human hyper-IgE syndrome: singular or plural?
Zhang Q; Boisson B; Béziat V; Puel A; Casanova JL
Mamm Genome; 2018 Aug; 29(7-8):603-617. PubMed ID: 30094507
[TBL] [Abstract][Full Text] [Related]
12. Inherited human ZNF341 deficiency.
Béziat V; Fieschi C; Momenilandi M; Migaud M; Belaid B; Djidjik R; Puel A
Curr Opin Immunol; 2023 Jun; 82():102326. PubMed ID: 37080116
[TBL] [Abstract][Full Text] [Related]
13. STAT3 Hyper-IgE Syndrome-an Update and Unanswered Questions.
Tsilifis C; Freeman AF; Gennery AR
J Clin Immunol; 2021 Jul; 41(5):864-880. PubMed ID: 33932191
[TBL] [Abstract][Full Text] [Related]
14. Mosaic IL6ST variant inducing constitutive GP130 cytokine receptor signaling as a cause of neonatal onset immunodeficiency with autoinflammation and dysmorphy.
Materna-Kiryluk A; Pollak A; Gawalski K; Szczawinska-Poplonyk A; Rydzynska Z; Sosnowska A; Cukrowska B; Gasperowicz P; Konopka E; Pietrucha B; Grzywa TM; Banaszak-Ziemska M; Niedziela M; Skalska-Sadowska J; Stawiński P; Śladowski D; Nowis D; Ploski R
Hum Mol Genet; 2021 Apr; 30(3-4):226-233. PubMed ID: 33517393
[TBL] [Abstract][Full Text] [Related]
15. [Hyper-IgE syndrome with mutation in STAT3 gene - case report and literature review].
Heropolitańska-Pliszka E; Pietrucha B; Mikołuć B; Bernatowska E
Med Wieku Rozwoj; 2009; 13(1):19-25. PubMed ID: 19648655
[TBL] [Abstract][Full Text] [Related]
16. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.
Al Khatib S; Keles S; Garcia-Lloret M; Karakoc-Aydiner E; Reisli I; Artac H; Camcioglu Y; Cokugras H; Somer A; Kutukculer N; Yilmaz M; Ikinciogullari A; Yegin O; Yüksek M; Genel F; Kucukosmanoglu E; Baki A; Bahceciler NN; Rambhatla A; Nickerson DW; McGhee S; Barlan IB; Chatila T
J Allergy Clin Immunol; 2009 Aug; 124(2):342-8, 348.e1-5. PubMed ID: 19577286
[TBL] [Abstract][Full Text] [Related]
17. The signal transducer and activator of transcription 3 at the center of the causative gene network of the hyper-IgE syndrome.
Minegishi Y
Curr Opin Immunol; 2023 Feb; 80():102264. PubMed ID: 36435159
[TBL] [Abstract][Full Text] [Related]
18. A deep intronic splice mutation of
Khourieh J; Rao G; Habib T; Avery DT; Lefèvre-Utile A; Chandesris MO; Belkadi A; Chrabieh M; Alwaseem H; Grandin V; Sarrot-Reynauld F; Sénéchal A; Lortholary O; Kong XF; Boisson-Dupuis S; Picard C; Puel A; Béziat V; Zhang Q; Abel L; Molina H; Marr N; Tangye SG; Casanova JL; Boisson B
Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16463-16472. PubMed ID: 31346092
[TBL] [Abstract][Full Text] [Related]
19. Hyper-IgE syndrome, 2021 update.
Minegishi Y
Allergol Int; 2021 Oct; 70(4):407-414. PubMed ID: 34419355
[TBL] [Abstract][Full Text] [Related]
20. Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes.
Freeman AF; Holland SM
Pediatr Res; 2009 May; 65(5 Pt 2):32R-37R. PubMed ID: 19190525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
